Matches in Wikidata for { <http://www.wikidata.org/entity/Q90068664> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- Q90068664 description "article scientifique publié en 2017" @default.
- Q90068664 description "artículu científicu espublizáu en xunu de 2017" @default.
- Q90068664 description "scientific article published on 01 June 2017" @default.
- Q90068664 description "wetenschappelijk artikel" @default.
- Q90068664 description "наукова стаття, опублікована в червні 2017" @default.
- Q90068664 name "Updated overall survival (OS) analysis from the international, phase 3, randomized, placebo-controlled RESORCE trial of regorafenib for patients with hepatocellular carcinoma (HCC) who progressed on sorafenib treatment" @default.
- Q90068664 name "Updated overall survival (OS) analysis from the international, phase 3, randomized, placebo-controlled RESORCE trial of regorafenib for patients with hepatocellular carcinoma (HCC) who progressed on sorafenib treatment" @default.
- Q90068664 type Item @default.
- Q90068664 label "Updated overall survival (OS) analysis from the international, phase 3, randomized, placebo-controlled RESORCE trial of regorafenib for patients with hepatocellular carcinoma (HCC) who progressed on sorafenib treatment" @default.
- Q90068664 label "Updated overall survival (OS) analysis from the international, phase 3, randomized, placebo-controlled RESORCE trial of regorafenib for patients with hepatocellular carcinoma (HCC) who progressed on sorafenib treatment" @default.
- Q90068664 prefLabel "Updated overall survival (OS) analysis from the international, phase 3, randomized, placebo-controlled RESORCE trial of regorafenib for patients with hepatocellular carcinoma (HCC) who progressed on sorafenib treatment" @default.
- Q90068664 prefLabel "Updated overall survival (OS) analysis from the international, phase 3, randomized, placebo-controlled RESORCE trial of regorafenib for patients with hepatocellular carcinoma (HCC) who progressed on sorafenib treatment" @default.
- Q90068664 P1433 Q90068664-343880B9-21E3-4574-926E-3B14B7E2F521 @default.
- Q90068664 P1476 Q90068664-D2FA3F1F-959B-403A-B006-9F0E7907CE5F @default.
- Q90068664 P2093 Q90068664-07539E0B-CEAF-46E7-9510-23DFF54A969E @default.
- Q90068664 P2093 Q90068664-31382BE7-B10E-4794-BDB9-263648C304FB @default.
- Q90068664 P2093 Q90068664-3FBEB4A3-DE95-48A3-952F-EFE302456C23 @default.
- Q90068664 P2093 Q90068664-42E7A4A6-75AA-4C29-9ECE-3AD9063B84F6 @default.
- Q90068664 P2093 Q90068664-7CD740D8-8FB3-497D-ADA4-6520BC641EE7 @default.
- Q90068664 P2093 Q90068664-8138BFB1-FA6B-4B9B-B30E-95235D5A24F4 @default.
- Q90068664 P2093 Q90068664-8743039A-2DEA-4C3E-9473-E0BDC4569F0B @default.
- Q90068664 P2093 Q90068664-8F95E9B3-E87C-4D40-9DAF-D2D601D81C3A @default.
- Q90068664 P2093 Q90068664-923C13C2-5837-44CF-8C18-4B4F6F78A7BE @default.
- Q90068664 P2093 Q90068664-942FC579-17B3-4DF4-A6E2-C89498CF2710 @default.
- Q90068664 P2093 Q90068664-9A6D8B41-A2BC-4851-8F36-6B023CA2D287 @default.
- Q90068664 P2093 Q90068664-B5CB2446-9D74-4508-BF3F-BE90BD951C87 @default.
- Q90068664 P2093 Q90068664-C543421F-887E-4CC8-AAE9-DAF6134170D7 @default.
- Q90068664 P2093 Q90068664-C9AF2D18-FF1D-4DAB-8255-8E4C44A68EB5 @default.
- Q90068664 P2093 Q90068664-CE7F3952-BCE3-4D94-90A8-A7EB2A0B8635 @default.
- Q90068664 P2093 Q90068664-D93CAC4F-AC37-4F3B-9506-C6489BD90754 @default.
- Q90068664 P2093 Q90068664-DCBA4A23-DC53-4E25-BDF6-3464304330AE @default.
- Q90068664 P2093 Q90068664-EC67B82F-070B-472E-A3AA-091BBD42BEC2 @default.
- Q90068664 P2093 Q90068664-ED392E03-4036-4862-A8E2-914421FD2BDA @default.
- Q90068664 P2093 Q90068664-EE930DD8-6D53-4C72-A87B-8A09EE46DACE @default.
- Q90068664 P304 Q90068664-8B88D04E-3233-46C8-A14A-06642313B1EE @default.
- Q90068664 P31 Q90068664-4ECF17AF-5587-4C46-9926-A549D5D3CCBF @default.
- Q90068664 P356 Q90068664-09D79F25-EDE5-487A-B86B-74CBFB28D663 @default.
- Q90068664 P478 Q90068664-9BC582D4-DAAD-4219-BAC4-1C28B8A5CA1F @default.
- Q90068664 P50 Q90068664-1CD7C313-399A-4FD9-8F24-6DB0C927FA4E @default.
- Q90068664 P577 Q90068664-B376C0E9-B6C3-4DF3-9999-68EE64794787 @default.
- Q90068664 P921 Q90068664-50AD9B9C-FD3B-49FB-8E70-7093715A23BC @default.
- Q90068664 P921 Q90068664-801BDF8B-E9F0-47B5-A947-844FA8C0578A @default.
- Q90068664 P356 MDX262.008 @default.
- Q90068664 P1433 Q326122 @default.
- Q90068664 P1476 "Updated overall survival (OS) analysis from the international, phase 3, randomized, placebo-controlled RESORCE trial of regorafenib for patients with hepatocellular carcinoma (HCC) who progressed on sorafenib treatment" @default.
- Q90068664 P2093 "Alessandro Granito" @default.
- Q90068664 P2093 "Annette Baumhauer" @default.
- Q90068664 P2093 "Gerold Meinhardt" @default.
- Q90068664 P2093 "Gianluca Masi" @default.
- Q90068664 P2093 "Guohong Han" @default.
- Q90068664 P2093 "Gyorgy Bodoky" @default.
- Q90068664 P2093 "Isabelle Ollivier-Hourmand" @default.
- Q90068664 P2093 "Jean-Pierre Bronowicki" @default.
- Q90068664 P2093 "Marie-Aude LeBerre" @default.
- Q90068664 P2093 "Masatoshi Kudo" @default.
- Q90068664 P2093 "Olivier Rosmorduc" @default.
- Q90068664 P2093 "Osamu Yokosuka" @default.
- Q90068664 P2093 "Paul J Ross" @default.
- Q90068664 P2093 "Philippe Merle" @default.
- Q90068664 P2093 "Rene Gerolami" @default.
- Q90068664 P2093 "Resorce Investigators" @default.
- Q90068664 P2093 "Shukui Qin" @default.
- Q90068664 P2093 "Tianqiang Song" @default.
- Q90068664 P2093 "Valeriy Breder" @default.
- Q90068664 P2093 "Yi-Hsiang Huang" @default.
- Q90068664 P304 "iii140" @default.
- Q90068664 P31 Q13442814 @default.
- Q90068664 P356 "10.1093/ANNONC/MDX262.008" @default.
- Q90068664 P478 "28 Suppl 3" @default.
- Q90068664 P50 Q37393143 @default.
- Q90068664 P577 "2017-06-01T00:00:00Z" @default.
- Q90068664 P921 Q269829 @default.
- Q90068664 P921 Q42824827 @default.